BGM Group (BGM) Competitors $7.41 -0.22 (-2.88%) Closing price 04:00 PM EasternExtended Trading$7.46 +0.05 (+0.67%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BGM vs. KYMR, XENE, AMRX, VKTX, ARWR, CRNX, MOR, NAMS, RARE, and HCMShould you be buying BGM Group stock or one of its competitors? The main competitors of BGM Group include Kymera Therapeutics (KYMR), Xenon Pharmaceuticals (XENE), AMNEAL PHARMACEUTICALS (AMRX), Viking Therapeutics (VKTX), Arrowhead Pharmaceuticals (ARWR), Crinetics Pharmaceuticals (CRNX), MorphoSys (MOR), NewAmsterdam Pharma (NAMS), Ultragenyx Pharmaceutical (RARE), and HUTCHMED (HCM). These companies are all part of the "pharmaceutical products" industry. BGM Group vs. Its Competitors Kymera Therapeutics Xenon Pharmaceuticals AMNEAL PHARMACEUTICALS Viking Therapeutics Arrowhead Pharmaceuticals Crinetics Pharmaceuticals MorphoSys NewAmsterdam Pharma Ultragenyx Pharmaceutical HUTCHMED BGM Group (NASDAQ:BGM) and Kymera Therapeutics (NASDAQ:KYMR) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings. Do analysts rate BGM or KYMR? Kymera Therapeutics has a consensus price target of $58.76, indicating a potential upside of 39.25%. Given Kymera Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Kymera Therapeutics is more favorable than BGM Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BGM Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Kymera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 3.11 Which has better earnings and valuation, BGM or KYMR? BGM Group has higher earnings, but lower revenue than Kymera Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBGM Group$25.10M28.70-$1.44MN/AN/AKymera Therapeutics$47.07M64.10-$223.86M-$3.47-12.16 Is BGM or KYMR more profitable? BGM Group has a net margin of 0.00% compared to Kymera Therapeutics' net margin of -616.03%. BGM Group's return on equity of 0.00% beat Kymera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BGM GroupN/A N/A N/A Kymera Therapeutics -616.03%-31.60%-27.12% Which has more volatility & risk, BGM or KYMR? BGM Group has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, Kymera Therapeutics has a beta of 2.17, meaning that its stock price is 117% more volatile than the S&P 500. Does the media favor BGM or KYMR? In the previous week, Kymera Therapeutics had 8 more articles in the media than BGM Group. MarketBeat recorded 8 mentions for Kymera Therapeutics and 0 mentions for BGM Group. Kymera Therapeutics' average media sentiment score of 1.14 beat BGM Group's score of 0.00 indicating that Kymera Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment BGM Group Neutral Kymera Therapeutics Positive SummaryKymera Therapeutics beats BGM Group on 9 of the 13 factors compared between the two stocks. Get BGM Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricBGM GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$741.80M$3.13B$5.75B$9.85BDividend YieldN/A2.28%6.67%4.51%P/E RatioN/A20.8978.4326.42Price / Sales28.70458.96546.94119.09Price / CashN/A44.5237.0558.92Price / Book1.019.9310.916.06Net Income-$1.44M-$53.38M$3.29B$266.28M7 Day Performance-3.52%0.05%0.01%-0.76%1 Month Performance-11.26%7.08%7.06%3.83%1 Year Performance6.93%11.92%50.09%24.39% BGM Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMBGM GroupN/A$7.41-2.9%N/A-8.2%$741.80M$25.10M0.00298Positive NewsGap UpKYMRKymera Therapeutics3.4756 of 5 stars$43.12+3.1%$58.76+36.3%-6.5%$3.08B$44.71M-12.40170News CoveragePositive NewsXENEXenon Pharmaceuticals2.6985 of 5 stars$38.60+1.2%$53.20+37.8%-3.3%$2.97B$9.43M-10.85210News CoveragePositive NewsAnalyst ForecastOptions VolumeAMRXAMNEAL PHARMACEUTICALS3.2463 of 5 stars$9.36+0.8%$11.60+24.0%+12.4%$2.94B$2.79B937.448,100Positive NewsVKTXViking Therapeutics4.2798 of 5 stars$26.08+0.9%$86.92+233.4%-54.1%$2.93BN/A-17.0320Positive NewsAnalyst RevisionARWRArrowhead Pharmaceuticals4.2164 of 5 stars$21.13+2.0%$43.14+104.2%+21.3%$2.92B$3.55M-16.52400News CoverageAnalyst ForecastInsider TradeCRNXCrinetics Pharmaceuticals3.8141 of 5 stars$30.90+2.7%$68.86+122.8%-33.4%$2.92B$1.39M-7.53210News CoveragePositive NewsMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730NAMSNewAmsterdam Pharma3.8445 of 5 stars$25.31+2.4%$41.55+64.2%+56.4%$2.85B$45.56M-15.644News CoveragePositive NewsRAREUltragenyx Pharmaceutical4.5209 of 5 stars$29.34+0.2%$81.50+177.8%-43.4%$2.83B$560.23M-5.311,294News CoverageHCMHUTCHMED2.0416 of 5 stars$15.74-1.2%$28.00+77.9%-12.4%$2.74B$630.20M0.001,811Gap Down Related Companies and Tools Related Companies KYMR Competitors XENE Competitors AMRX Competitors VKTX Competitors ARWR Competitors CRNX Competitors MOR Competitors NAMS Competitors RARE Competitors HCM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGM) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BGM Group Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BGM Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
